Two people in Australia have died after developing Guillain-Barré Syndrome (GBS) in cases that may be related to COVID vaccination, the The****utic Goods Administration (TGA) has revealed.
The women – one aged 77 from Victorian and the other 81 from New South Wales – reportedly developed symptoms of the rare immune disorder after receiving AstraZeneca’s COVID-19 vaccine.
The deaths were confirmed in the regulator’s , after the Vaccine Safety Investigation Group (VSIG) reviewed the cases on 7 December and confirmed that they appeared ‘consistent with being related to vaccination with AstraZeneca’.
The women – one aged 77 from Victorian and the other 81 from New South Wales – reportedly developed symptoms of the rare immune disorder after receiving AstraZeneca’s COVID-19 vaccine.
The deaths were confirmed in the regulator’s , after the Vaccine Safety Investigation Group (VSIG) reviewed the cases on 7 December and confirmed that they appeared ‘consistent with being related to vaccination with AstraZeneca’.
Comment